March 13, 2025
Cambridge-Based Medical Device Startup Surgicure Technologies Raises $1.785M Seed Round to Advance Airway Management Solutions
Cambridge, Massachusetts, United States—
Surgicure Technologies, specializing in airway management solutions, has secured $1.785 million in a Seed funding round. The investment, announced on March 12, 2025, was led by LaunchPad Venture Group, BBE Ventures, Beacon Angels, Gurtin Ventures, SBXi, Sidecar Angels, Tidal River, and TiE Angels. The funding will accelerate the commercialization of Surgicure’s flagship product, the Horseshoe™, which aims to enhance patient safety and streamline clinical workflows.
About Surgicure Technologies
Founded in 2018 by Irena King, Surgicure Technologies develops medical devices designed to optimize patient breathing, improve deployment speed, and contribute to overall safety in both civilian and military healthcare settings. The company’s flagship product, the Horseshoe™, offers a patented solution for securing endotracheal (ET) tubes, preventing facial pressure injuries, and ensuring effective oral care. This innovation is expected to significantly reduce complications such as accidental extubations, which can lead to severe patient outcomes, including cardiac arrest and brain damage.
Purpose of financing
With the newly raised capital, Surgicure plans to accelerate the commercialization and adoption of the Horseshoe™ in hospitals and emergency medical settings. The funds will also support further product development, regulatory approvals, and expansion into new markets.
CEO’s Insights
Irena King, CEO & Founder of Surgicure Technologies, stated:
“This investment marks a transformative moment for Surgicure Technologies. Current airway management practices often rely on outdated and unreliable methods such as adhesive tape, leading to preventable complications. Our breakthrough solution is designed to directly address these challenges and improve patient outcomes.”
Investor Perspective
Ian Levine, Managing Director of LaunchPad Venture Group, also expressed confidence in Surgicure’s potential, stating:
“At LaunchPad Venture Group, we are thrilled to support Surgicure’s vision. Their technology addresses critical unmet medical needs and has the potential to set a new standard of care in airway management. We look forward to partnering with their talented team to bring this solution to healthcare providers worldwide.”
Conclusion
Surgicure Technologies is committed to setting new standards in airway management through innovation. By leveraging cutting-edge design and engineering, the company aims to provide medical professionals with tools that enhance safety and efficiency in patient care.
For updates, visit Surgicure Technologies on Linkedin.